Save
Email
Print
Share
RSSBrowse News Stories
171 to 180 of 890 stories
view headlines only
-
ID1 Protein Boosts Lung Cancer in Smokers, Non-Smokers; Potential Anti-Oncogenic Target
July 18, 2011 — Lung cancer is strongly correlated with smoking, and most lung cancer patients are current or former smokers. But it is not rare in nonsmokers. Now, a team of researchers shows that a protein called ... > full story -
Telomere Length Linked to Emphysema Risk
July 15, 2011 — Telomeres, the body's own cellular clocks, may be a crucial factor underlying the development of emphysema, according to new ... > full story -
Endosonography Followed by Surgical Staging Improves Quality of Life, According to New Study
July 7, 2011 — Patients who underwent endoscopic testing prior to surgery for lung cancer had significantly better quality of life at the end of the staging process, with no significant difference in costs between ... > full story -
Non-Small Cell Lung Cancer: TEMLA Shows Higher Diagnostic Yield Than EBUS or EUS in Largest Reported Series to Date
July 7, 2011 — In the largest reported series yet to compare transcervical extended mediastinal lymphadenectomy (TEMLA) with endoscopic and surgical primary staging and restaging of non-small cell lung cancer ... > full story -
Lung Cancer: Amrubicin Improved Response Rate and Progression-Free Survival Vs. Topotecan in Phase III Trial
July 7, 2011 — Lung cancer patients given amrubicin (Calsed) as a second-line therapy had a significantly improved response rate and longer progression-free survival than patients treated with topotecan (Hycamtin), ... > full story -
First Whole-Genome Lung Cancer Study: Review of Lung Tumor from a Patient Who Never Smoked
July 6, 2011 — A first-of-its-kind study of a patient with lung cancer who never smoked is shedding new light on the deadly disease. Researchers for the first time sequenced the entire DNA and RNA of a patient with ... > full story -
Celecoxib May Prevent Lung Cancer in Former Smokers
July 6, 2011 — Celecoxib may emerge as a potent chemopreventive agent for lung cancer, according to a recent study. Researchers tested celecoxib, a COX-2 inhibitor, among patients who were former smokers and found ... > full story -
Increased Investment in Thoracic Surgical Expertise Increased UK Lung Cancer Resection Rate
July 6, 2011 — Increased investment in specialist thoracic surgical expertise can lead to a significant rise in the lung cancer resection rate, based on data from England between 2008 and ... > full story -
Elderly Dutch Lung Patients' Survival Improved by New Treatment Options Between 2003-2009
July 6, 2011 — New developments such as stereotactic ablative radiotherapy and improvements in surgical care in early-stage lung cancer have led to large survival gains for elderly Dutch patients, according to a ... > full story -
Women, Elderly, Minorities Poorly Represented in Lung Cancer Drug Trial Data Submitted to US FDA
July 6, 2011 — Women, older people and minorities are enrolled less frequently in lung cancer drug trials and the numbers do not reflect the prevalence of lung cancer in these populations, according to new ... > full story
Search ScienceDaily
Number of stories in archives: 138,622
more 
